MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
4.270
-0.070 (-1.61%)
Aug 10, 2026, 2:35 PM EDT - Market open
MiMedx Group Market Cap
MiMedx Group has a market cap or net worth of $622.4 million as of August 10, 2026. Its market cap has decreased by -40.08% in one year.
Market Cap
622.40M
Enterprise Value
503.76M
1-Year Change
-40.08%
Ranking
Category
Stock Price
$4.27
ChartMarket Cap Chart
Since February 12, 2008, MiMedx Group's market cap has increased from $34.30M to $622.40M, an increase of 1,714.57%. That is a compound annual growth rate of 16.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 622.40M | -37.93% |
| Dec 31, 2025 | 1.00B | -29.07% |
| Dec 31, 2024 | 1.41B | 38.51% |
| Dec 29, 2023 | 1.02B | 222.97% |
| Dec 30, 2022 | 316.00M | -53.35% |
| Dec 31, 2021 | 677.40M | -32.82% |
| Dec 31, 2020 | 1.01B | 19.81% |
| Dec 31, 2019 | 841.60M | 323.34% |
| Dec 31, 2018 | 198.80M | -85.80% |
| Dec 29, 2017 | 1.40B | 44.30% |
| Dec 30, 2016 | 970.30M | -4.97% |
| Dec 31, 2015 | 1.02B | -17.19% |
| Dec 31, 2014 | 1.23B | 44.18% |
| Dec 31, 2013 | 855.20M | 156.74% |
| Dec 31, 2012 | 333.10M | 297.02% |
| Dec 30, 2011 | 83.90M | -2.67% |
| Dec 31, 2010 | 86.20M | 173.65% |
| Dec 31, 2009 | 31.50M | -81.05% |
| Dec 31, 2008 | 166.20M | 384.55% |
| Feb 12, 2008 | 34.30M | - |
View and export this data all the way back to 2008. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 686.48M |
| Achieve Life Sciences | 682.68M |
| Phathom Pharmaceuticals | 679.13M |
| REGENXBIO | 661.45M |
| Faeth Therapeutics | 628.74M |
| Nuvectis Pharma | 617.42M |
| ARS Pharmaceuticals | 611.71M |
| Altimmune | 598.98M |